BlackRock Fund Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
BIT
NI
SFM
BlackRock Fund Advisors's ANGO Position: Q4 2016 in Review
BlackRock Fund Advisors increased its AngioDynamics (ANGO) stake by 23% in Q4 2016, buying an estimated $7.7M and bringing the position to 2,513,035 shares worth $42.4M. The position accounts for 0.01% of the portfolio, ranked #1784.
BlackRock Fund Advisors first reported a position in ANGO in Q2 2013 and has held it in 15 quarters since. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.
- BlackRock Fund Advisors held 2,513,035 shares of AngioDynamics worth $42.4M as of Q4 2016.
- BlackRock Fund Advisors bought 461,654 AngioDynamics shares in Q4 2016, an estimated $7.7M.
- AngioDynamics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1784 holding.
- BlackRock Fund Advisors first reported a position in AngioDynamics in Q2 2013 and has held it in 15 quarters since.
- 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.